Mullins CD - Search Results

1

Rating of Included Trials on the Efficacy-Effectiveness Spectrum: development of a new tool for systematic reviews.

Wieland LS, Berman BM, Altman DG, Barth J, Bouter LM, D'Adamo CR, Linde K, Moher D, Mullins CD, Treweek S, Tunis S, van der Windt DA, Zwarenstein M, Witt C. Wieland LS, et al. Among authors: mullins cd. J Clin Epidemiol. 2017 Apr;84:95-104. doi: 10.1016/j.jclinepi.2017.01.010. Epub 2017 Feb 7. J Clin Epidemiol. 2017. PMID: 28188898 Free PMC article.

2

Uncertainty in assessing value of oncology treatments.

Mullins CD, Montgomery R, Tunis S. Mullins CD, et al. Oncologist. 2010;15 Suppl 1:58-64. doi: 10.1634/theoncologist.2010-S1-58. Oncologist. 2010. PMID: 20237219 Free article.

3

Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials.

Mullins CD, Whicher D, Reese ES, Tunis S. Mullins CD, et al. Pharmacoeconomics. 2010;28(10):969-76. doi: 10.2165/11536160-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831305

4

Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer.

Mullins CD, Montgomery R, Abernethy AP, Hussain A, Pearson SD, Tunis S; American Society of Clinical Oncology. Mullins CD, et al. J Clin Oncol. 2012 Feb 20;30(6):661-6. doi: 10.1200/JCO.2011.35.5198. Epub 2012 Jan 17. J Clin Oncol. 2012. PMID: 22253467

5

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S. Basch E, et al. Among authors: mullins cd. J Clin Oncol. 2012 Dec 1;30(34):4249-55. doi: 10.1200/JCO.2012.42.5967. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071244 Review.

6

Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.

Sonnad SS, Mullins CD, Whicher D, Goldsack JC, Mohr PE, Tunis SR. Sonnad SS, et al. Among authors: mullins cd. Contemp Clin Trials. 2013 Nov;36(2):356-61. doi: 10.1016/j.cct.2013.08.008. Epub 2013 Aug 31. Contemp Clin Trials. 2013. PMID: 23999501

7

Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.

Mullins CD, Rattinger GB, Kuznik A, Koren MJ. Mullins CD, et al. Clin Ther. 2008;30 Pt 2:2204-16. doi: 10.1016/j.clinthera.2008.12.007. Clin Ther. 2008. PMID: 19281915

8

It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.

Mullins CD, Sanchez RJ. Mullins CD, et al. J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4. J Manag Care Pharm. 2011. PMID: 22074667

9

Continuous patient engagement in comparative effectiveness research.

Mullins CD, Abdulhalim AM, Lavallee DC. Mullins CD, et al. JAMA. 2012 Apr 18;307(15):1587-8. doi: 10.1001/jama.2012.442. JAMA. 2012. PMID: 22511684 No abstract available.

10

The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model.

Mitikiri ND, Reese ES, Hussain A, Onukwugha E, Pritchard D, Dubois R, Mullins CD. Mitikiri ND, et al. Among authors: mullins cd. J Comp Eff Res. 2013 Nov;2(6):605-18. doi: 10.2217/cer.13.70. J Comp Eff Res. 2013. PMID: 24236799 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters